Fabtech Technologies
- P/E
- 9.94
Key Fundamentals
MicrocapHealthcare Equipment & SuppliesHealthcarePrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 13.60%
- Debt to Equity
- 0.17
- EPS (TTM)
- ₹13.31
- Book Value
- ₹98.78
- Market Cap
- —
- P/E (TTM)
- 9.94
- P/B
- 1.34
- ROE
- 12.50%
- Dividend Yield
- 0.46%
- EBITDA
- ₹55.60 Cr
- 52W High
- ₹258.00
- 52W Low
- ₹115.10
- Day Range
- ₹125.37 – ₹134.40
- Volume
- 96,034
Peer Comparison
Healthcare › Medical Equipment › Healthcare Research, Analytics & Technology
| ₹417.50 | 76.05 | ₹16,536 Cr | 3.47 | 0.31% | 7.78% | 9.99% | ₹3,600 Cr | ₹221 Cr | |
| ₹617.10 | 37.04 | ₹14,947 Cr | 4.43 | 0.37% | 14.40% | 18.80% | ₹3,813 Cr | ₹401 Cr | |
| ₹276.10 | — | ₹7,549 Cr | 11.39 | 0.00% | −81.50% | −79.50% | ₹9 Cr | −₹353 Cr | |
| ₹497.85 | 27.89 | ₹2,195 Cr | 4.53 | 0.41% | 18.90% | 25.20% | ₹419 Cr | ₹80 Cr | |
| ₹132.30 | 9.94 | ₹589 Cr | 1.34 | 0.46% | 12.50% | 13.60% | ₹418 Cr | ₹49 Cr | |
| ₹11.42 | 13.13 | ₹161 Cr | 5.44 | 0.00% | 16.50% | 18.50% | ₹85 Cr | ₹13 Cr | |
| Median 6 companies | ₹346.80 | 27.89 | ₹4,872 Cr | 4.48 | 0.34% | 13.45% | 16.05% | ₹419 Cr | ₹64 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 46
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 77
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 50
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 59
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 21
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 51
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has delivered good profit growth of 35.8% CAGR over last 5 years
Weaknesses
2- Earnings include an other income of Rs.23.3 Cr.
- Company has high debtors of 182 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 7 | 6 | 6 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 50.34
- Neutral
- MACD (12,26,9)
- −3.97
- Bullish
- SMA (50)
- 139.73
- Bearish
- SMA (200)
- 151.00
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +27.71% |
|---|---|
| 3Y | +28.43% |
| 1Y | +25.69% |
| TTM | +14.16% |
Net profit
| 5Y | +36.56% |
|---|---|
| 3Y | +19.98% |
| 1Y | −17.39% |
| TTM | +41.00% |
Operating cash flow
| 5Y | Outflow narrowed by ₹9 Cr |
|---|---|
| 3Y | Outflow narrowed by ₹14 Cr |
| 1Y | Outflow narrowed by ₹36 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −0.57 pp |
|---|---|
| 3Y | −4.37 pp |
| 1Y | −3.41 pp |
| TTM | +0.03 pp |
Revenue by year
| Mar 2020 | ₹133 Cr |
|---|---|
| Mar 2021 | ₹121 Cr |
| Mar 2022 | ₹257 Cr |
| Mar 2023 | ₹194 Cr |
| Mar 2024 | ₹226 Cr |
| Mar 2025 | ₹327 Cr |
| Mar 2026 | ₹411 Cr |
Net profit by year
| Mar 2020 | ₹12.00 Cr |
|---|---|
| Mar 2021 | ₹8.00 Cr |
| Mar 2022 | ₹23.00 Cr |
| Mar 2023 | ₹22.00 Cr |
| Mar 2024 | ₹27.00 Cr |
| Mar 2025 | ₹46.00 Cr |
| Mar 2026 | ₹38.00 Cr |
Quarterly Results
₹ Cr| Particulars | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 58.74 | 104 | 135 | 68.01 | 121 | 62.76 | 159 | 74.98 | 92.09 |
| Expenses | 54.15 | 81.45 | 117 | 74.22 | 91.02 | 74.36 | 136 | 70.74 | 81.97 |
| Operating Profit | 4.59 | 22.87 | 18.36 | −6.21 | 30.46 | −11.6 | 22.21 | 4.24 | 10.11 |
| OPM % | 7.81% | 21.92% | 13.61% | −9.13% | 25.07% | −18.48% | 14.01% | 5.65% | 10.98% |
| Other Income | 2.36 | 1.75 | 3.29 | 2.75 | 3.18 | 7.1 | 9.85 | 3.15 | 13.9 |
| Interest | 0.24 | 0.43 | 1.09 | 1.34 | 1.07 | 0.87 | 0.88 | 0.86 | 1.03 |
| Depreciation | 0.7 | 0.69 | 0.63 | 1.39 | 1.31 | 1.31 | 1.29 | 1.3 | 1.26 |
| PBT | 6.01 | 23.5 | 19.93 | −6.19 | 31.26 | −6.68 | 29.89 | 5.23 | 21.72 |
| Tax % | 14.81% | 12.98% | 24.23% | −1.13% | 10.08% | −15.12% | 26.23% | 19.69% | 30.85% |
| Net Profit | 5.12 | 20.46 | 15.09 | −6.13 | 28.11 | −5.68 | 22.06 | 4.21 | 15.02 |
| EPS (₹) | 1.58 | 6.32 | 4.66 | −1.89 | 8.68 | −1.28 | 4.96 | 0.95 | — |
Sep 2026: from the results filed on 28 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 133 | 121 | 257 | 194 | 226 | 327 | 411 | 418 |
| Expenses | 119 | 110 | 225 | 169 | 191 | 288 | 376 | 372 |
| Operating Profit | 14 | 11 | 32 | 25 | 35 | 39 | 35 | 45 |
| OPM % | 11% | 9% | 12% | 13% | 15% | 12% | 9% | 11% |
| Other Income | 5 | 2 | 4 | 10 | 6 | 27 | 23 | 23 |
| Interest | 2 | 2 | 3 | 5 | 3 | 3 | 4 | 4 |
| Depreciation | 0 | 0 | 2 | 2 | 2 | 3 | 5 | 5 |
| PBT | 16 | 11 | 31 | 28 | 36 | 60 | 48 | 60 |
| Tax % | 27% | 29% | 25% | 22% | 24% | 23% | 21% | — |
| Net Profit | 12 | 8 | 23 | 22 | 27 | 46 | 38 | 49 |
| EPS (₹) | Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank. | Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank. | 84.28 | 78 | 92.44 | 14.34 | 8.63 | 13.31 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 7% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 3 | 3 | 3 | 32 | 44 |
| Reserves | 38 | 46 | 65 | 86 | 129 | 141 | 375 |
| Borrowings | 1 | 9 | 21 | 35 | 13 | 84 | 70 |
| Other Liabilities | 84 | 70 | 83 | 89 | 125 | 170 | 164 |
| Total Liabilities | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
| Fixed Assets | 2 | 2 | 5 | 4 | 22 | 94 | 78 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 7 | 17 | 20 | 21 | 15 | 26 |
| Other Assets | 109 | 116 | 150 | 190 | 226 | 318 | 550 |
| Total Assets | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 64 | −9 | −3 | −14 | 60 | −36 | 0 |
| Investing | −28 | 4 | −9 | 2 | −30 | −20 | −112 |
| Financing | −23 | 6 | 8 | 12 | −12 | 36 | 190 |
| Net Cash Flow | 13 | 1 | −4 | 0 | 18 | −20 | 78 |
| Free Cash Flow | 64 | −9 | −4 | −14 | 59 | −61 | 5 |
| CFO/OP | 417 | −65 | 4 | −15 | 196 | −68 | 36 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 135 | 120 | 187 | 156 | 168 | 182 |
| Inventory Days | 22 | 39 | 17 | 69 | 88 | 119 | 32 |
| Days Payable | 82 | 150 | 136 | 215 | 195 | 198 | 159 |
| Cash Conversion Cycle | 51 | 25 | 1 | 41 | 49 | 89 | 55 |
| Working Capital Days | −19 | 15 | 30 | 65 | 63 | 53 | 90 |
| ROCE % | — | 26% | 48% | 31% | 28% | 22% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fabtech Technologies insights
39 extracted metrics across FY20–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · Jun 2026PPT
- Q4 FY26 concall · Apr 2026Transcript PPT
- Concall · Feb 2026PPT
- 28 Oct 2026
- 15 Oct 2025
- 11 Sep 2025
- 12 Aug 2025
- General announcements 30 Oct 2026
Frequently Asked Questions about Fabtech Technologies
What does Fabtech Technologies Ltd do?
Where is Fabtech Technologies Ltd (FABTECH) listed?
Which sector does Fabtech Technologies Ltd belong to?
What is the PE ratio of Fabtech Technologies Ltd?
What is the 52-week high and low of Fabtech Technologies Ltd?
Does Fabtech Technologies Ltd pay dividends?
What is the Return on Equity (ROE) of Fabtech Technologies Ltd?
Company Information
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FABTECH.md for Fabtech Technologies Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.